Beranda › Kanker Kolon › New York › New York City
Uji klinis Kanker Kolon di New York City, NY
22 studi untuk Kanker Kolon mencari peserta di lokasi sekitar New York City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Menerima pesertaFase 3
- Memorial Sloan Kettering Cancer Center ( Site 0095), New York
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Menerima pesertaFase 3
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New York
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Menerima pesertaFase 1/2
- Columbia University, New York
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Menerima pesertaFase 1/2
- NYU Langone Health Perlmutter Cancer Center, New York
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Menerima pesertaFase 3
- Icahn School of Medicine At Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Menerima peserta
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Menerima pesertaFase 2/3
- Mount Sinai West, New York
- Mount Sinai Hospital, New York
- Manhattan Eye Ear and Throat Hospital, New York
- dan 2 lainnya
Shield Post-Approval Study Protocol
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- NYU Langone, New York
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Menerima pesertaFase 1
- Xencor Investigative Site, New York
- Xencor Investigative Site, New York
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- Memorial Sloan Kettering Cancer Center 53rd street., New York
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Menerima pesertaFase 1/2
- NYU Langone Medical Center, New York
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Menerima pesertaFase 1
- Research Site, New York
- Research Site, New York
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Menerima pesertaFase 1
- NYU Langone, New York
- Memorial Sloan Kettering Cancer Center, New York
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Menerima pesertaFase 1/2
- Perlmutter Cancer Center at NYU Langone Health, New York
- Memorial Sloan-Kettering Cancer Center, New York
- Columbia University, New York
Brodalumab in the Treatment of Immune-Related Adverse Events
Menerima pesertaFase 1
- Columbia University Irving Medical Center, New York
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
Menerima pesertaStudi observasional
- NYU Langone Health, New York
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
Menerima pesertaStudi observasional
- Memorial Sloan Kettering Cancer Center, New York
Phase II Trial of Lung Chemoemobolization
Menerima pesertaFase 2
- Memorial Sloan Kettering Cancer Center, New York
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Memorial Sloan Kettering Cancer Center, New York
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Menerima pesertaFase 3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- dan 1 lainnya
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, New York
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Menerima pesertaFase 1/2
- NYU Langone Health, New York
Uji klinis Kanker Kolon di kota lain
- Boston, MA22 studi
- Houston, TX20 studi
- Los Angeles, CA16 studi
- Nashville, TN16 studi
- St. Louis, MO15 studi
- Arlington, VA15 studi
- Chicago, IL14 studi
- San Antonio, TX14 studi
- Baldwin Park, CA14 studi
- Baltimore, MD13 studi
- Tampa, FL13 studi
- Washington, DC12 studi
Studi lain di New York City
- Kanker Payudara136 studi
- Kanker Paru Non-Sel Kecil121 studi
- Kanker (semua jenis)109 studi
- Kanker Prostat103 studi
- Kanker Metastatik93 studi
- Kanker Kolorektal78 studi
- Kanker Ovarium69 studi
- Kanker Paru60 studi
- Mieloma Multipel60 studi
- Kanker Pankreas60 studi
- Kanker Endometrium52 studi
- Leukemia Mieloid Akut51 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.